We increasingly extend both the quality and quantity of life for what were fatal diseases; AIDS/HIV comes readily to mind. But treatment is also increasingly expensive, even with insurance coverage. In some instances, co-pays are equivalent to the annual median household income. A new paper looks at a readily available source of funding. (Spoiler alert: it doesn't involve new taxes.)
The cost of pharmaceuticals is high for a number of reasons. A new study considers our out-of-pocket spending and increased use of medications, rather than more expensive surgery or hospitalization as a driver we can control.